HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutation analysis of the PLOD1 gene: an efficient multistep approach to the molecular diagnosis of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA).

Abstract
The kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA) is an inheritable connective tissue disorder characterized by a deficiency of lysyl hydroxylase due to mutations in PLOD1. We describe a mutation analysis strategy for the PLOD1 gene using either cDNA or gDNA or a combination thereof, which allows for reliable, time-effective and efficient mutation detection in patients with EDS VIA. We report the results obtained in 9 index patients from 12 unrelated families: three patients were homozygous for three novel mutations (p.Ile454IlefsX2, p.Ala667Thr, and p.His706Arg), four patients were homozygous for the common duplication of exons 10-16, one patient was compound heterozygous for the common duplication and p.Ile454IlefsX2, and one patient was homozygous for p.Arg319X.
AuthorsCecilia Giunta, Ann Randolph, Beat Steinmann
JournalMolecular genetics and metabolism (Mol Genet Metab) 2005 Sep-Oct Vol. 86 Issue 1-2 Pg. 269-76 ISSN: 1096-7192 [Print] United States
PMID15979919 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • DNA, Complementary
  • Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase
Topics
  • Adolescent
  • Adult
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Child
  • Child, Preschool
  • DNA Primers
  • DNA, Complementary
  • Ehlers-Danlos Syndrome (diagnosis, genetics)
  • Exons
  • Female
  • Homozygote
  • Humans
  • Kyphosis (diagnosis, genetics)
  • Male
  • Molecular Sequence Data
  • Mutation
  • Polymerase Chain Reaction
  • Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase (chemistry, genetics)
  • Sequence Homology, Amino Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: